Nov 302017
 

By Talent4Boards Team

Talent4Boards - Great Talent builds Great Boards

– USA, NJ – Bellerophon Therapeutics, Inc. (Nasdaq:BLPH), a clinical-stage biotherapeutics company, today announced the appointment of Ted Wang, Ph.D., Chief Investment Officer of Puissance Capital Management, to its Board of Directors.… => Read more

Bellerophon Therapeutics adds Ted Wang to its Board of Directors

From:: Bellerophon Therapeutics adds Ted Wang to its Board of Directors

Sorry, the comment form is closed at this time.

%d bloggers like this: